Care
The company will use the funds to expand its value-based cancer care network and extend its reach with health plans, employers and providers.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
The partners created a registry to generate real-world data using consenting U.S. patients' medical records to further research in stage 1 to 3 breast cancer.
The company's portable, battery-operated and Bluetooth-connected device with RPM capabilities enables patients to complete respiratory treatments from anywhere.
The life sciences company's Gut Intelligence Test will be available in 200 CVS locations and through the drugstore chain online.
Peloton for Business includes access to the company's commercial bike, an employee benefit program, exclusive programming and offers for partner organizations.
The not-for-profit health insurer's patients in New York and Connecticut will have access to in-home services after hospitalization via DocGo.
The smartphone-sized device offers continuous monitoring of respiration rate while allowing patient mobility.
The company's revenue increased in Q2 of this year to $13.1 million compared to $10.7 million in the first quarter – still below the $18.3 million reported in Q2 2022.
The collaboration will allow MedArrive's members, including Medicaid beneficiaries, to access 24/7 cardiology services from their homes.